| RS2148348451 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2148348645 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148348931 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148348983 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2148349819 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148349944 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148352851 |
F9
|
Health Risk |
Pathogenic |
HEMOPHILIA B BRANDENBURG, HEMOPHILIA B BRANDENBURG |
| RS2148352869 |
F9
|
Health Risk |
Pathogenic |
Hemophilia B leyden, Hemophilia B leyden |
| RS2148352878 |
F9
|
Health Risk |
Pathogenic |
Hemophilia B leyden, Hemophilia B leyden |
| RS2148353000 |
F9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2148353009 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS2148354097 |
GJB3
|
Health Risk |
Likely pathogenic |
— |
| RS2148355967 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi Goutieres syndrome |
| RS2148356172 |
F9
|
Health Risk |
Likely pathogenic |
— |
| RS2148356221 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2148357901 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2148358021 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2148358457 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148358474 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148358634 |
SLC6A8
|
Health Risk |
Pathogenic |
— |
| RS2148359722 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2148359769 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2148360598 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2148360995 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148361002 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148361006 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148361153 |
F9
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia, X-linked |
| RS2148361177 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148361240 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS2148362390 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS2148362786 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148362976 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148363006 |
SLC6A8
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Creatine transporter deficiency |
| RS2148363178 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148363211 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148363243 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Thyroid cancer |
| RS2148363661 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Inborn genetic diseases |
| RS2148363723 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148363775 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2148363957 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148363973 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148364124 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148364156 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148364395 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148364489 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2148365710 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2148367245 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2148367254 |
F9
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia, X-linked |
| RS2148367304 |
F9
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2148367725 |
F9
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2148367882 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS2148367990 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2148368332 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2148368738 |
IKBKG
|
Health Risk |
Likely pathogenic |
Immunodeficiency 33, Immunodeficiency 33 |
| RS2148370601 |
BCAP31
|
Health Risk |
Pathogenic |
BCAP31-related disorder, BCAP31-related disorder |
| RS2148371451 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2148372150 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS2148373123 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2148373432 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, Cardiovascular phenotype |
| RS2148373642 |
FHL1
|
Health Risk |
Likely pathogenic |
Myopathy, reducing body |
| RS2148373814 |
FHL1
|
Health Risk |
Likely pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2148375467 |
FHL1
|
Health Risk |
Likely pathogenic |
X-linked myopathy with postural muscle atrophy, Nonpapillary renal cell carcinoma |
| RS2148375686 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2148375860 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2148376330 |
FHL1
|
Health Risk |
Pathogenic |
— |
| RS2148378327 |
TAF1
|
Health Risk |
Pathogenic |
— |
| RS2148378462 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2148378774 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2148382857 |
IKBKG
|
Health Risk |
Pathogenic |
Autoinflammatory disease, X-linked |
| RS2148382861 |
IKBKG
|
Health Risk |
Pathogenic |
Autoinflammatory disease, X-linked |
| RS2148383945 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2148384040 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2148385082 |
IKBKG
|
Health Risk |
Likely pathogenic |
— |
| RS2148385109 |
IKBKG
|
Health Risk |
Likely pathogenic |
— |
| RS2148385141 |
IKBKG
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 1, Ectodermal dysplasia and immunodeficiency 1 |
| RS2148385355 |
IKBKG
|
Health Risk |
Pathogenic |
Immunodeficiency 33, Immunodeficiency 33 |
| RS2148386073 |
IKBKG
|
Health Risk |
Likely pathogenic |
— |
| RS2148388506 |
ABCD1
|
Health Risk |
Likely pathogenic |
— |
| RS2148388526 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148388538 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148388645 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148388671 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148388674 |
ABCD1
|
Health Risk |
Likely pathogenic |
X-linked cerebral adrenoleukodystrophy, X-linked cerebral adrenoleukodystrophy |
| RS2148388737 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148388748 |
ABCD1
|
Health Risk |
Pathogenic |
— |
| RS2148388883 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148388971 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148388980 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2148388986 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389007 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389181 |
ABCD1
|
Health Risk |
Pathogenic |
— |
| RS2148389233 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389338 |
ABCD1
|
Health Risk |
Likely pathogenic |
— |
| RS2148389350 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389462 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389513 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389516 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389537 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389592 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389670 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |